149 related articles for article (PubMed ID: 1646701)
1. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer.
Beerman H; Smit VT; Kluin PM; Bonsing BA; Hermans J; Cornelisse CJ
Cytometry; 1991; 12(2):147-54. PubMed ID: 1646701
[TBL] [Abstract][Full Text] [Related]
2. Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.
Bonsing BA; Devilee P; Cleton-Jansen AM; Kuipers-Dijkshoorn N; Fleuren GJ; Cornelisse CJ
Cancer Res; 1993 Aug; 53(16):3804-11. PubMed ID: 8101767
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of primary lung carcinomas and their lymph node metastases.
Volm M; Mattern J; Vogt-Schaden M; Wayss K
Anticancer Res; 1987; 7(1):71-6. PubMed ID: 3032072
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of flow cytometry for metastatic potential in breast cancer.
Schmidt H; Wei JP; Yeh KA
Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
[TBL] [Abstract][Full Text] [Related]
7. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
[TBL] [Abstract][Full Text] [Related]
9. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
10. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
12. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
Bergers E; Baak JP; van Diest PJ; Willig AJ; Los J; Peterse JL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH
Mod Pathol; 1997 Aug; 10(8):762-8. PubMed ID: 9267817
[TBL] [Abstract][Full Text] [Related]
14. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
15. Response to Beerman et al.: "Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer".
Kute T
Cytometry; 1991; 12(2):155-6. PubMed ID: 2049972
[No Abstract] [Full Text] [Related]
16. Comparison of DNA stemline and cell kinetics between primary breast cancer and its lymph node metastasis.
Chang DB; Yang PC; Chang KJ; Luh KT; Kuo SH
Anal Quant Cytol Histol; 1993 Feb; 15(1):32-8. PubMed ID: 8385953
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum.
Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045
[TBL] [Abstract][Full Text] [Related]
19. Evidence of clonal divergence in colorectal carcinoma.
Tollenaar RA; Bonsing BA; Kuipers-Dijkshoorn NJ; Hermans J; van de Velde CJ; Cornelisse CJ; Fleuren GJ
Cancer; 1997 Apr; 79(7):1304-14. PubMed ID: 9083151
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
